“venbio” Archives

in
Entry Author Date Location
Checkmate Pharma Clinches $27M for More Studies in Skin Cancer 06/15/17 Boston
Bio Roundup: Big Apple Mo’, Checkpoint Yes and No, CAR-T Death & More 05/12/17 National
VenBio Settles Immunomedics Litigation, SeaGen Nixes Cancer Drug Deal 05/05/17 New York
VenBio-Backed Directors Wrest Control of Immunomedics Board 03/03/17 New York
Bio Roundup: CRISPR Drama, Marathon and PhRMA, the Price of Vision & More 02/17/17 National
Impel NeuroPharma Receives $36,000,000 Series C Financing Round 12/06/16 Seattle
Corvus Pharmaceuticals Receives $75,000,000 Series B Funding 09/30/15 San Francisco
East Coast Biotech Roundup: Editas, Checkmate, Ovid & More 08/14/15 Boston
Checkmate Pharmaceuticals Obtains $20,000,000 Series A Round 08/13/15 Boston
Moving on From Sarepta, Krieg Lands at Cancer Startup Checkmate Pharma 08/12/15 Boston
Metacrine Obtains $36,000,000 Series A Funding 08/05/15 San Diego
Precision BioSciences Lands $26M for Gene-Editing Technology 05/11/15 Raleigh Durham
West Coast Biotech Roundup: Versant, BayBio/CHI Merger, von Emster 12/11/14 San Francisco
Amid String of Exits for VenBio, a Founding Partner Leaves, Too 12/05/14 San Francisco
New Research Could (Finally) Remove RNAi’s Commercial Limitations 11/17/14 National
Canaan Closes $675M Fund, One Of Venture’s Ten Largest This Year 10/16/14 New York
Who Needs Biotech VCs, Anyway? 07/15/14 San Francisco
West Coast Biotech Roundup: Seragon, Ambrx, Pregenen, and More 07/03/14 San Diego
VenBio Scores Again as Genentech Pays $1.7B+ for Seragon Pharma 07/02/14 San Diego
As Its Investors Reap Returns, venBio Aims for a Bigger Second Fund 06/10/14 San Francisco
Lou Tartaglia Leaves Third Rock to Run High-Drama RNAi Startup 06/09/14 San Diego
Labrys Turns Stalled Pfizer Program into $200M+ Teva Buyout 06/03/14 San Francisco
Seragon Pharmaceuticals Obtains $30,000,000 Series A Financing 10/18/13 San Diego
VenBio’s Goodman Builds an Inside Periscope on Biotech Acquisitions 01/23/13 San Francisco
Solstice Biologics Garners $18,000,000 Series A Round 01/05/13 San Francisco
Labrys Biologics Secures $31,000,000 Series A Funding Round 01/04/13 San Francisco
San Diego Life Sciences Roundup: Regulus, Aragon, Cytori, & More 10/05/12 San Diego
Aragon Pharmaceuticals Receives $49,999,988 Series D Round 09/26/12 San Diego
Theraclone’s Cliff Stocks Joins “Reinventing Biotech” Lineup Apr. 3 03/27/12 Seattle
iPierian Shakeup Continues, as Chairman Corey Goodman, Scientist Doug Melton Exit Stem Cell Startup 06/15/11 San Francisco
Page 1 of 2 next page »